The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of pyrroledione analogs as potent transient receptor potential canonical channel 5 inhibitors.EBI
China Pharmaceutical University
Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation.EBI
Chinese Academy of Sciences
Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model.EBI
Goldfinch Bio
Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.EBI
University of Nebraska Medical Center
Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4).EBI
TBA
Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 Channels.EBI
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Moe) and Hubei Provinc
Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitorsBDB
Incyte
Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors.BDB
University of Namur